Chemotherapy risk assessment for elderly patients.
10.3881/j.issn.1000-503X.2014.05.019
- Author:
He-li GAO
1
;
Chun-mei BAI
1
Author Information
1. Department of Oncology,PUMC Hospital,CAMS and PUMC,Beijing 100032,China.
- Publication Type:Journal Article
- MeSH:
Aged;
Aged, 80 and over;
Antineoplastic Combined Chemotherapy Protocols;
therapeutic use;
Humans;
Neoplasms;
drug therapy;
Risk Assessment
- From:
Acta Academiae Medicinae Sinicae
2014;36(5):551-555
- CountryChina
- Language:Chinese
-
Abstract:
The incidence of cancer increases with age and most elderly patients will choose chemotherapy, and the complications of cytotoxic chemotherapy will be more common in these patients. Therefore, it is particularly important to predict the chemotherapy toxicity for the elderly patients. This review article summarizes the recent chemotherapy risk assessment tools for the elderly patients.
